Biotech stocks are in focus as leverage in finance fuels speculative phases ahead of FDA decisions. The NASDAQ Biotech Index is up 3.4% in five sessions, though traders warn of sudden leveraged selloffs on adverse news. “We came out flat,” Lathan said. “We came as a group together and we just told each other we’ve got to pick up the energy because it was a long game ahead of us. They were hitting us early and doing a lot of things that we weren’t prepared for. And we just had to put our cleats in the ground and get grounded to the game.” By leveraging tools such as machine learning, natural language processing , and predictive analytics, companies can make real-time adjustments, forecast with greater confidence, and gain a competitive edge in a fast-changing financial landscape. Bank of America’s latest data indicates leveraged ETFs saw $1.1 billion in inflows last week, mainly targeting energy stocks. Investors are betting on supply constraints to push crude higher, though leverage in finance magnifies exposure to downside shocks if demand weakens.
